Next Article in Journal
Nanotopographical 3D-Printed Poly(ε-caprolactone) Scaffolds Enhance Proliferation and Osteogenic Differentiation of Urine-Derived Stem Cells for Bone Regeneration
Next Article in Special Issue
Biodistribution Analysis of an Anti-EGFR Antibody in the Rat Brain: Validation of CSF Microcirculation as a Viable Pathway to Circumvent the Blood-Brain Barrier for Drug Delivery
Previous Article in Journal
Safety and Efficacy of the Bordetella bronchiseptica Vaccine Combined with a Vegetable Oil Adjuvant and Multi-Omics Analysis of Its Potential Role in the Protective Response of Rabbits
Previous Article in Special Issue
Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment
 
 

Order Article Reprints

Journal: Pharmaceutics, 2022
Volume: 14
Number: 1435

Article: Improving the Efficacy and Accessibility of Intracranial Viral Vector Delivery in Non-Human Primates
Authors: by Devon J. Griggs, Aaron D. Garcia, Wing Yun Au, William K. S. Ojemann, Andrew Graham Johnson, Jonathan T. Ting, Elizabeth A. Buffalo and Azadeh Yazdan-Shahmorad
Link: https://www.mdpi.com/1999-4923/14/7/1435

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (articlereprints@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop